Financial news
The newsroom
Headlines from the Federal Reserve, ECB, Bank of Japan, Bank of England, SEC EDGAR, the White House and the DOJ. Context notes are written automatically by software from each headline, not by an editor. They are neutral and information-only, Kresmion publishes no buy or sell recommendations.
Public RSS feeds · refreshed every 30 minutes
8582 items from SEC EDGAR · clear filters
- 8-K - INTEST CORP (0001036262) (Filer)
Automated noteIntest Corp filed a Form 8-K on July 31, 2026, containing Item 2.02 results of operations and financial condition, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits.
- 8-K - Everus Construction Group, Inc. (0002015845) (Filer)
Automated noteEverus Construction Group, Inc. filed a Form 8-K with the SEC on July 31 2026, containing a Regulation FD Disclosure under Item 7.01.
- 8-K - Karyopharm Therapeutics Inc. (0001503802) (Filer)
Automated noteKaryopharm Therapeutics Inc. filed a Form 8-K with the SEC on July 31 2026, reporting under Item 8.01 “Other Events.”
- 8-K - Co-Diagnostics, Inc. (0001692415) (Filer)
Automated noteCo-Diagnostics, Inc. filed a Form 8-K reporting a material definitive agreement, unregistered sales of equity securities, and the inclusion of its financial statements and related exhibits.
- 8-K - Beyond Air, Inc. (0001641631) (Filer)
Automated noteBeyond Air, Inc. filed a Form 8-K on July 31, 2026, reporting a material definitive agreement, unregistered sales of equity securities, other events, and accompanying financial statements and exhibits.
- 8-K - Organon & Co. (0001821825) (Filer)
Automated noteOrganon & Co. filed a Form 8-K with the SEC on July 31, 2026, containing a Regulation FD disclosure and accompanying financial statements and related exhibits.
- 8-K - IMPERIAL OIL LTD (0000049938) (Filer)
Automated noteImperial Oil Ltd filed a Form 8-K reporting the departure of certain officers and the appointment of new officers, along with disclosed compensatory arrangements for the appointed officers, under Item 5.02.
- 8-K - IRADIMED CORP (0001325618) (Filer)
Automated noteIradiMed Corp filed a Form 8-K under Item 8.01 (Other Events) with the SEC on July 31 2026, accession number 0001628280-26-051240.
- 8-K - PATRIOT NATIONAL BANCORP INC (0001098146) (Filer)
Automated notePatriot National Bancorp filed a Form 8-K on July 31, 2026, containing a Regulation FD disclosure and the company’s financial statements and related exhibits.
- 8-K - OPPENHEIMER HOLDINGS INC (0000791963) (Filer)
Automated noteOppenheimer Holdings Inc. filed a Form 8-K on July 31, 2026, reporting its results of operations and financial condition and providing its financial statements and related exhibits.
- 8-K - IMPERIAL OIL LTD (0000049938) (Filer)
Automated noteImperial Oil Ltd filed a Form 8-K on July 31, 2026, disclosing its results of operations and financial condition for the period, along with the related financial statements and exhibits.
- 8-K - BORGWARNER INC (0000908255) (Filer)
Automated noteBorgWarner Inc. filed a Form 8-K on July 31, 2026 reporting director/officer departures and appointments, related compensation arrangements, a Regulation FD disclosure, and accompanying financial statements and exhibits.
- 8-K12G3 - Jushi Holdings Inc. (0001909747) (Filer)
Automated noteJushi Holdings filed an 8-K12G3 reporting unregistered equity sales, material modifications to security-holder rights, director and officer departures, elections, appointments and compensation arrangements, amendments to articles/bylaws and fiscal year, other events, and related financial statements.
- 8-K - Pelican Acquisition II Corp (0002122392) (Filer)
Automated notePelican Acquisition II Corp filed a Form 8-K reporting a material definitive agreement, unregistered equity sales, changes to directors and officers, amendments to its charter and fiscal year, and accompanying financial statements and exhibits.
- 8-K - AETHLON MEDICAL INC (0000882291) (Filer)
Automated noteAethlon Medical Inc. filed a Form 8-K on July 31, 2026 reporting material modifications to security-holder rights, amendments to its articles of incorporation/bylaws including a change in fiscal year, and accompanying financial statements and exhibits.
- 8-K - Oxford Square Capital Corp. (0001259429) (Filer)
Automated noteOxford Square Capital Corp filed a Form 8-K on July 31, 2026, reporting its results of operations and financial condition, providing a Regulation FD disclosure, and attaching financial statements and related exhibits.
- 8-K - Lulu's Fashion Lounge Holdings, Inc. (0001780201) (Filer)
Automated noteLulu's Fashion Lounge Holdings Inc. filed an 8-K on July 31, 2026 reporting entry into a material definitive agreement, creation of a direct financial obligation or off-balance-sheet arrangement, and accompanying financial statements and exhibits.
- 8-K - WisdomTree, Inc. (0000880631) (Filer)
Automated noteWisdomTree, Inc. filed a Form 8-K on July 31, 2026 (Accession No. 0001214659-26-009324) reporting results of operations and financial condition (Item 2.02), other events (Item 8.01), and accompanying financial statements and exhibits (Item 9.01).
- 8-K - Moleculin Biotech, Inc. (0001659617) (Filer)
Automated noteMoleculin Biotech, Inc. filed a Form 8-K on July 31, 2026, including a Regulation FD disclosure and accompanying financial statements and exhibits.
- 8-K - IMPERIAL OIL LTD (0000049938) (Filer)
Automated noteImperial Oil Ltd filed a Form 8-K on July 31, 2026, reporting a Regulation FD disclosure and providing its financial statements and related exhibits as required under Items 7.01 and 9.01.
- 8-K - COLGATE PALMOLIVE CO (0000021665) (Filer)
Automated noteColgate-Palmolive filed a Form 8-K on July 31, 2026, reporting its results of operations and financial condition and providing its financial statements and related exhibits.
- 8-K - AbbVie Inc. (0001551152) (Filer)
Automated noteAbbVie Inc. filed a Form 8-K on July 31, 2026, reporting its results of operations and financial condition for the period and providing related financial statements and exhibits.
- 8-K - IES Holdings, Inc. (0001048268) (Filer)
Automated noteIES Holdings filed a Form 8-K on July 31, 2026, reporting its results of operations and financial condition, a Regulation FD disclosure, other events, and accompanying financial statements and exhibits.
- 8-K - Seer, Inc. (0001726445) (Filer)
Automated noteSeer, Inc. filed a Form 8-K on July 31, 2026, including Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits) under accession number 0001193125-26-326858.
- 8-K - Perella Weinberg Partners (0001777835) (Filer)
Automated notePerella Weinberg Partners filed a Form 8-K on July 31 2026, disclosing its results of operations and financial condition for the reporting period.
- 8-K - CubeSmart (0001298675) (Filer)
Automated noteCubeSmart filed a Form 8-K on July 31, 2026, reporting its results of operations and financial condition, providing a Regulation FD disclosure, and attaching its financial statements and related exhibits.
- 8-K - CubeSmart, L.P. (0001300485) (Filer)
Automated noteCubeSmart, L.P. filed a Form 8-K on July 31 2026, reporting its results of operations and financial condition, providing a Regulation FD disclosure, and attaching financial statements and related exhibits.
- 8-K - Gates Industrial Corp Ltd. (0001718512) (Filer)
Automated noteGates Industrial Corp Ltd filed a Form 8-K on July 31, 2026, including Item 2.02 results of operations and financial condition, and Item 9.01 financial statements and exhibits.
- 8-K - Perimeter Solutions, Inc. (0001880319) (Filer)
Automated notePerimeter Solutions, Inc. filed a Form 8-K on July 31 2026 (Accession No. 0001880319-26-000044), reporting its results of operations and financial condition and providing its financial statements and related exhibits.
- 8-K - Dragonfly Energy Holdings Corp. (0001847986) (Filer)
Automated noteDragonfly Energy Holdings Corp filed a Form 8-K reporting entry into a material definitive agreement, creation of a direct financial obligation/off-balance-sheet arrangement, unregistered sales of equity securities, a Regulation FD disclosure, and related financial statements and exhibits.